InvestorsHub Logo
Followers 46
Posts 4459
Boards Moderated 0
Alias Born 07/26/2010

Re: None

Monday, 03/02/2020 12:28:44 PM

Monday, March 02, 2020 12:28:44 PM

Post# of 2791
Posted on February 27, 2020...The only company with a target for vimentim is Nascent Biotech Inc. (OTCMKT: NBIO). Their lead candidate is pritumumab which was a phase 2 brain cancer asset in Japan. They have redone their cell line for study and on the cusp of starting their phase 1 cancer trial.

https://insiderfinancial.com/top-coronavirus-stocks-backed-by-scientific-evidence/179657/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News